Table V.
Mapping of outcome instruments into Outcome Measures Recommended for use in Randomized Clinical Trials domains
| Outcome instrument (year) | Domains | ||||
|---|---|---|---|---|---|
| Adverse event | Life impact | Resource use | Pathophysiological manifestations | Technical considerations | |
| PBS tool18 (2019) | X | X | |||
| Assessing Clubfoot Treatment tool40 (2017) | X | X | X | X | |
| Evertor score41 (2014) | X | X | X | ||
| Bangla Clubfoot Tool23,42 (2014) | X | X | X | X | |
| Bhaskar relapse assessment tool43 (2013) | X | X | X | ||
| IMAR-Clubfoot scale25 (2009) | X | X | |||
| Richards classification44 (2008) | X | X | |||
| Clubfoot Assessment Protocol21 (2005) | X | X | |||
| International Clubfoot Study Group31 (2003) | X | X | X | ||
| Roye’s disease-specific instrument19 (2001) | X | ||||
| Ezra clubfoot score46 (2000) | X | X | X | ||
| Pirani score13 (1999) | X | X | X | ||
| Diméglio score14 (1995) | X | X | X | ||
| Catterall classification16 (1991) | X | X | |||
| Harrold and Walker classification15 (1983) | X | X | |||
| Laaveg and Ponseti functional rating system17 (1980) | X | X | X | ||
PBS, Pirani/Böhm/Sinclair.